Global Oral AntiDiabetic Drug Market will reach USD 35.91 Billion by 2022: Zion Market Research

Jan 12, 2017 05:56 am UTC| Business

Sarasota, FL, Jan. 12, 2017 -- Zion Market Research has published a new report titled “Oral Antidiabetic Drug Market by Drug Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2...

Interfaith Group Greets New Year with Fellowship and Commitment at the Church of Scientology’s Fort Harrison Religious Retreat

Jan 12, 2017 04:54 am UTC| Business

CLEARWATER, Fla., Jan. 11, 2017 -- On January 21st, the Church of Scientology Flag Service Organization will host a gathering of members from the religious community at the Church’s Fort Harrison in downtown Clearwater....

TESARO Receives Complete Response Letter for Rolapitant IV from U.S. FDA

Jan 12, 2017 04:30 am UTC| Business

No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not requiredInvestor conference call and webcast scheduled for tomorrow at 8:30AM ET WALTHAM, Mass.,...

Juniper Systems Launches New CT7G Rugged Tablet

Jan 12, 2017 03:16 am UTC| Business

BIRMINGHAM, United Kingdom, Jan. 11, 2017 -- Rugged computer manufacturer Juniper Systems Limited has announced that its new CT7G Rugged Tablet is in production and now shipping. Running on the Android® 6.0 operating...

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ophthotech Corporation To Contact The Firm Before Lead Plaintiff Deadline

Jan 12, 2017 01:18 am UTC| Business

NEW YORK, Jan. 11, 2017 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Ophthotech Corporation (“Ophthotech” or the “Company”) (NASDAQ:OPHT) of the March 13, 2017 deadline to seek...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Endologix, Inc. and Certain Officers – ELGX

Jan 12, 2017 00:51 am UTC| Business

NEW YORK, Jan. 11, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Endologix, Inc. (“Endologix” or the “Company”) (NASDAQ:ELGX) and certain of its officers. The class action, filed in...

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline

Jan 12, 2017 00:29 am UTC| Business

NEW YORK, Jan. 11, 2017 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE:NVO) of the March 13, 2017 deadline to seek the role...